PD-L1 Control Slides

Immunohistochemistry - general carcinoma markers · class III · Until 13/02/2033

Registration no.
80000230085
Process no.
25351381889202280
Status
Until 13/02/2033
Device type
Immunohistochemistry - general carcinoma markers (IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS EM GERAL)
Risk class
III
Registration holder
AGILENT TECHNOLOGIES BRASIL LTDA CNPJ 03.290.250/0001-00 · 84 registrations
Manufacturer
AGILENT TECHNOLOGIES, INC. · United States
Published
13/02/2023
Valid until
13/02/2033
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other immunohistochemistry - general carcinoma markers registrations (24 in total, see all)

ProductClass HolderPublishedStatus
Família Marcadores de Carcinoma Geral - CM III
10287411790
III ROCHE DIAGNÓSTICA BRASIL LTDA 04/05/2026 Until 04/05/2036
Família Marcadores de Carcinoma Geral - CM II
10287411791
III ROCHE DIAGNÓSTICA BRASIL LTDA 04/05/2026 Until 04/05/2036
Família Marcadores de Carcinomas Geral – CM I
10287411768
III ROCHE DIAGNÓSTICA BRASIL LTDA 10/11/2025 Until 10/11/2035
INSM1 (SP493) Rabbit Monoclonal Primary Antibody
10287411763
III ROCHE DIAGNÓSTICA BRASIL LTDA 15/09/2025 Until 15/09/2035
CD68 (SP251v18) Rabbit Monoclonal Antibody
10287411757
III ROCHE DIAGNÓSTICA BRASIL LTDA 01/09/2025 Until 01/09/2035
MARCADOR DE CARCINOMA - MIOGENINA
80000230091
III AGILENT TECHNOLOGIES BRASIL LTDA 21/10/2024 Until 21/10/2034
Familia Câncer Geral VENTANA
10287411701
III ROCHE DIAGNÓSTICA BRASIL LTDA 19/08/2024 Until 19/08/2034
Família MMR IHC
10287411690
III ROCHE DIAGNÓSTICA BRASIL LTDA 22/04/2024 Until 22/04/2034